BD acquires Accuri Cytometers BD , a respected global technology company, announced the completion of its acquisition of Accuri Cytometers today, Inc., an Ann Arbor, Michigan-based business that develops and manufactures personal stream cytometers for researchers. The acquisition expands BD’s presence in to the emerging inexpensive personal stream cytometer space, and assists expand the usage of circulation cytometry technology by experts in parts of the world where simplicity and affordability are crucial. The acquisition of Accuri Cytometers complements and broadens BD’s offerings forever scientists by making movement cytometry more available to a wider target audience of researchers and clinicians, stated William Rhodes, President, BD Biosciences.There are virtually 100 different indications for the therapeutic usage of Botox. Mild unwanted effects, such as transient problems droopy or swallowing eyelids, occurred in approximately one-third of the individuals during the period of about 16 years. Researchers pointed out that a gradual upsurge in dosage over period resulted in far better alleviation of symptoms. When botulinum toxin, probably the most toxic chemicals known to mankind, is purified and injected in smaller amounts by an experienced clinician, it relaxes muscle mass and prevents involuntary muscles spasms. Jankovic and various other neurologists at BCM pioneered the usage of Botox as a therapeutic way for dystonia individuals in 1981.